Retension Pharmaceuticals, Clinical-Stage Biopharma for Hypertension, Files for Nasdaq Capital Market IPOTradingView·2 days ago, 09:18 PMOPY+3.16%
CoinShares CEO Jean-Marie Mognetti attends Oppenheimer Fintech Leaders ConferencePUBT·Sep 9 at 11:06 AMOPY+3.16%CSHR+0.85%
Oppenheimer (NYSE:OPY) Reaches New 12-Month High - What's Next?Market Beat·Sep 3 at 05:40 PMOPY+3.16%
SpaceX's big AI advantage is why this analyst thinks the stock could doubleMarketWatch·Sep 2 at 07:45 PMANTH
First Internet Bancorp to Participate in the Oppenheimer Fintech Leaders Conference | INBK Stock NewsStockTitan·Sep 2 at 12:22 PMINBK-0.14%OPY+3.16%
Is Oppenheimer’s Municipal Leadership Expansion Quietly Reframing Its Competitive Edge in Public Finance (OPY)?Simplywall·Sep 1 at 08:36 PMOPY+3.16%
Oppenheimer Welcomes Joel Berry II and Expands North Carolina Private Client Team Focused on Advising AthletesUnusual Whales·Aug 31 at 10:03 AMOPY+3.16%
OppFi management attends Oppenheimer Fintech Leaders Conference in SeptemberPUBT·Aug 26 at 09:29 AMOPFI+0.08%USB-P-1.07%
OppFi to Participate in September 2026 Conferences | OPFI Stock NewsStockTitan·Aug 25 at 12:05 PMOPFI+0.08%
Oppenheimer Hires Bruce Rideaux and Promotes Lauren Carter As Public Finance Business Continues to Expand | OPY Stock NewsStockTitan·Aug 24 at 07:00 AMOPY+3.16%
